Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin (after administration of adeno-associated viral vector encoding an inducible short hairpin RNA targeting claudin-5)

EU orphan designation number: EU/3/12/1007   
Active ingredient: 17-(Dimethylaminoethylamino)-17-demethoxygeldanamycin (after administration of adeno-associated viral vector encoding an inducible short hairpin RNA targeting claudin-5)
Indication: Treatment of retinitis pigmentosa
Sponsor: Avena Therapeutics Ltd
Trinity Research and Innovation, Trinity College Dublin, Dublin 2, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/11/2012 Orphan Designation EMA/OD/021/12 (2012)8888 of 28/11/2012